PERIPHERAL ARTERIAL DISEASE(PAD)
Clinical trials for PERIPHERAL ARTERIAL DISEASE(PAD) explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL ARTERIAL DISEASE(PAD) trials appear
Sign up with your email to follow new studies for PERIPHERAL ARTERIAL DISEASE(PAD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI contrast agent may improve artery blockage detection in legs
Diagnosis CompletedThis study tested two MRI methods for finding narrowed or blocked arteries in the pelvis and legs of 119 people with peripheral arterial disease (PAD). One method uses a special dye called ferumoxytol to make blood vessels stand out, while the other relies on natural blood flow. …
Matched conditions: PERIPHERAL ARTERIAL DISEASE(PAD)
Phase: PHASE2 • Sponsor: AMAG Pharmaceuticals, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Japanese PAD patients under the microscope: rivaroxaban safety check
Knowledge-focused CompletedThis study looked at the safety of the blood thinner rivaroxaban in 1500 Japanese patients with peripheral arterial disease (PAD) who had surgery to improve blood flow in their legs. Researchers used existing health records to track bleeding events and heart-related deaths. No ne…
Matched conditions: PERIPHERAL ARTERIAL DISEASE(PAD)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC